MS
Morgan Stanley
MS has a slight edge over OBT overall, supported by stronger modeled upside and lower modeled downside.
OBT
Orange County Bancorp, Inc.
OBT's outlook is improving, though it still trails on the overall score.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
OBT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
OBT's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like OBT.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
OBT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.9x | $33.19 | -17% |
| Fair | 10x | $37.40 | -6.2% |
| Current | 11x | $39.86 | — |
| Forward | 11x | $39.86 | — |
| Expensive | 12x | $43.61 | +9.4% |
Historical ranges are pointers, not guarantees.
OBT has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over OBT on the outlook, with more favorable valuation expectations.
OBT Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for OBT, with profitability improving.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over OBT on earnings, with more consistent year-over-year improvement.
OBT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.65 | -2.3% |
| Q3 2026 | $3.74 | +24% |
| Q2 2026 | $3.56 | +39% |
| Q1 2026 | $3.41 | +41% |
| Q4 2025 | $3.33 | +35% |
| Q3 2025 | $3.02 | +18% |
| Q2 2025 | $2.56 | -17% |
| Q1 2025 | $2.42 | -23% |
| Q4 2024 | $2.47 | -5.7% |
OBT earned $3.74 per share over the past year, up 24% from the year before.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over OBT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
OBT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $35.3M | +4.6% |
| Q2 2026 | $27.8M | -14% |
| Q1 2026 | $32.1M | +15% |
| Q4 2025 | $33M | +21% |
| Q3 2025 | $33.7M | +24% |
| Q2 2025 | $32.5M | +16% |
| Q1 2025 | $28M | +11% |
| Q4 2024 | $27.4M | +5.8% |
OBT's revenue is growing: $35M last quarter, up 4.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 49% | +10 points |
| Q2 2026 | 42% | -0.3 points |
| Q1 2026 | 45% | +5.1 points |
| Q4 2025 | 41% | +8.6 points |
| Q3 2025 | 39% | +24 points |
| Q2 2025 | 42% | +5.2 points |
| Q1 2025 | 40% | -5.6 points |
| Q4 2024 | 33% | -8.6 points |
OBT has the edge over MS on profitability, with a higher operating margin.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
OBT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26.5M | -11% |
| Q2 2026 | $12.3M | +$18M |
| Q1 2026 | $9.7M | +123% |
| Q4 2025 | $13.1M | +11% |
| Q3 2025 | $29.6M | +197% |
| Q2 2025 | -$5.7M | -162% |
| Q1 2025 | $4.3M | +117% |
| Q4 2024 | $11.7M | -24% |
OBT has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over OBT on shareholder dilution, with a more favorable share count trend.
OBT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +2.2K shares |
| 1 year | +0.3% | +45.7K shares |
| 3 years | +19% | +2.1M shares |
| 5 years | +27% | +2.9M shares |
OBT has 13M diluted shares, about the same as a year ago.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
OBT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -3.7x | Net Cash |
| Q2 2026 | -5.7x | Net Cash |
| Q1 2026 | -4.1x | Net Cash |
| Q4 2025 | -3.4x | Net Cash |
| Q3 2025 | -3.4x | Net Cash |
| Q2 2025 | -3.9x | Net Cash |
| Q1 2025 | -4.0x | Net Cash |
| Q4 2024 | -0.5x | Net Cash |
OBT has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
OBT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 66.4 | Neutral |
| Stochastic | 70.7 | Neutral |
OBT's weekly RSI is 66 (neutral) and its Stochastic is 71 (neutral).
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
OBT PE vs Financial Services Sector
| Metric | OBT | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 18% below |
| PE % | 67 | 63 | 4 pts above |
OBT has the edge over MS on valuation relative to its sector.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
OBT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $38.3 | 4.2% above |
| 20 week MA | $38.2 | 4.4% above |
| 50 week MA | $34.9 | 14% above |
| 100 week MA | $30.2 | 32% above |
| 200 week MA | $27.1 | 47% above |
OBT has the edge over MS on trend strength, trading above more of its moving averages.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.
OBT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $14.7 | $13.6 | -7.3% |
| 2021 | $13.6 | $19.7 | +45% |
| 2022 | $19.7 | $23.3 | +18% |
| 2023 | $23.3 | $30.1 | +29% |
| 2024 | $30.1 | $27.4 | -8.9% |
| 2025 | $27.4 | $28.7 | +4.5% |
| 2026 YTD | $28.7 | $39.9 | +39% |
OBT has the edge over MS on returns for 2026, with the stronger performance.